Table 1 Mutation frequencies of 25 myeloid genes
Variables | No. examined | Mutated no. | Percentage (%) |
---|---|---|---|
RAS signaling pathway | 426 | 37 | 8.7 |
āNRAS | 426 | 19 | 4.5 |
āKRAS | 426 | 6 | 1.4 |
āCBL | 426 | 13 | 3.1 |
Receptors/kinases | 426 | 9 | 2.1 |
āFLT3/ITD | 426 | 5 | 1.2 |
āJAK2 | 426 | 4 | 0.9 |
Transcription | 426 | 61 | 14.3 |
āRUNX1 | 426 | 52 | 12.2 |
āGATA2 | 426 | 11 | 2.6 |
DNA methylation | 426 | 104 | 24.4 |
āIDH1 | 426 | 4 | 0.9 |
āIDH2 | 426 | 18 | 4.2 |
āDNMT3A | 426 | 42 | 9.9 |
āTET2 | 426 | 59 | 13.8 |
Chromatin modification | 426 | 103 | 24.2 |
āASXL1 | 426 | 96 | 22.5 |
āEZH2 | 426 | 27 | 6.3 |
āMLL/PTD | 426 | 5 | 1.2 |
RNA splicing | 426 | 166 | 39 |
āU2AF1 | 426 | 31 | 7.3 |
āSRSF2 | 426 | 58 | 13.6 |
āSF3B1 | 426 | 47 | 11.0 |
āZRSR2 | 426 | 41 | 9.6 |
Cohesin | 426 | 31 | 7.3 |
āRAD21 | 426 | 0 | 0 |
āSTAG1 | 426 | 2 | 0.5 |
āSTAG2 | 426 | 27 | 6.3 |
āSMC1A | 426 | 2 | 0.5 |
āSMC3 | 426 | 0 | 0 |
Others | 426 | 55 | 12.9 |
āSETBP1 | 426 | 14 | 3.3 |
āTP53 | 426 | 41 | 9.6 |